Letter: Myelotoxicity and orthostatic hypotension of cyclocytidine (NSC-145668)
Related Experiment Videos
Cancer Treatment Reports
|March 1, 1976
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Short-course FAC-M versus 1 year of CMFVP in node-positive, hormone receptor-negative breast cancer: an intergroup study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1995
One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: a Southwest Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1993
Randomized comparison of cisplatin plus epirubicin or doxorubicin for advanced epithelial ovarian carcinoma. A multicenter trial.
American journal of clinical oncology·1992
Clinical significance of antibodies to bovine and human thrombin and factor V after surgical use of bovine thrombin.
American journal of clinical pathology·1992
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987